维普中文期刊产品整合服务
22篇 您的检索式:作者名="Portarena"
    题名 作者 年代 出处 被引量
1Association between increased tumor necrosis factor alpha levels and acquired Activated protein C resistance in patients with metastatic colorectal cancer显示文摘FERRONI P RIONDINO S PORTARENA I 2012International Journal of Colorectal Disease2012,27,12:1
2Potential clinical applications of poly ( ADP - ribose) polymerase (PARP) inhibitors 显示文摘TENTORI L PORTARENA I GRAZIANI G 2002Pharmacol Res2002,45,2:1
3Novel High-Sensitive D-Dimer Determination Predicts Chemotherapy-Associated Venous Thromboembolism in Intermediate Risk Lung Cancer Patients显示文摘Patrizia Ferroni Francesca Martini Ilaria Portarena Gioia Massimiani Silvia Riondino Francesca La Farina Sabrina Mariotti Fiorella Guadagni Mario Roselli 2012Clinical Lung Cancer2012,,6:1
4Predictive va- lue of high-sensitive D-dimer determination for chem- otherapy-associated venous thromboembolism in gas-trointestinal cancer patients显示文摘Roselli M Ferroni P Portarena I 2012Thrombosis and Hae- mostasis2012,108,6:1
5Novel High-Sensitive D-Dimer Determination Predicts Chemotherapy-Associated Venous Thromboembolism in Intermediate Risk Lung Cancer Patients显示文摘Patrizia Ferroni Francesca Martini Ilaria Portarena Gioia Massimiani Silvia Riondino Francesca La Farina Sabrina Mariotti Fiorella Guadagni Mario Roselli 2012Clinical Lung Cancer2012,,6:1
6Poten- tial clinical applications of poly ( ADP-ribose ) poly- merase(PARP) inhibitors显示文摘TENTORI L PORTARENA I GRAZIANI G 2002Pharmacol Res2002,45,2:1
7Inhibition of telomerase increases resistance of melanoma cells to temozolomide,but not to temozolomide combined with poly (adp-ribose) polymerase inhibitor显示文摘Tentori L Portarena I Barbarino M 2003Mol Pharmacol2003,63,1:1
8Potential clinlcal application of poly (ADP-ribose) polymerase inhibitors显示文摘Tentori L Portarena T I Graziani G 2002Pharmacol Res2002,45,2:1
9Potential clinical applications of poly (ADP-ribose) polymerase (PARP) inhibitors显示文摘Tentori L Portarena I Graziani G 2002Pharmacol Res2002,45,2:1
10Role of CA199 in predicting bevacizumab efficacy for metastatic colorectal cancer patients 显示文摘Formica V Massara MC Portarena I 2009Cancer Biomark2009,5,4:1
11Predictive value of high- sensitive D-dimer determination for chemotherapy-associated venous thromboembolism in gastrointestinal cancer patients 显示文摘Roselli M Ferroni P Portarena I 2012Thromb Haem- ost2012,1108,6:1
12Poly (ADP-ribose)polymer-ase inhibitor increases apoptosis and reduces necrosis induced by a DNA minor groove binding methyl sulfonate ester 显示文摘Tentori L Balduzzi A Portarena I 2001Cell Death Differ2001,8,8:1
13Potential clinical applications of poly(ADP-ribose) polymerase inhibitors显示文摘Tentori L Portarena I Graziani G 2002Pharmacol Res2002,45,:1
14Potential clinical applications of poly ( ADP-ribose ) polymerase ( PARP ) inhibitors 显示文摘Tentori L Portarena I Graziani G 2012Pharmacol Res2012,45,2:1
15Novel high-sensitiveD-dimer determination predicts chemotherapy-associatedvenous thromboembolism in intermediate risk lung cancerpatients显示文摘Ferroni P Martini F Portarena I 2012Clin Lung Cancer2012,13,6:1
16Effects of single or split exposure of leukemic cells to temozolomidc, combined with poly (ADP-ribose) polymerase inhibitors on cell growth, chromosomal aberrations and base excision repair components显示文摘Tentori L Portarena I Vernole P 2001Cancer Chemother Pharmacol2001,47,4:1
17Plasma plasminogen activa- tor Inhibitor-1 (PAI-1) levels in breast cancer-relationship with clini- cal outcome显示文摘Ferroni P Roselli M Portarena I 2014Anticancer Res2014,34,3:1
18Novel high-sensitiveD-Dimer determination predicts chemotherapy-associated venousthromboembolism in intermediate risk lung cancer patients 显示文摘Ferroni P Martini F Portarena I 2012Clin Lung Cancer2012,13,6:1
19CRH inhibits cell growth of human endometrial adenocarcinoma cells via CRH-receptor 1-mediated activation of cAMP-PKA pathway显示文摘Graziani G Tentori L Portarena I 0,,03:1
20Valproic acid increases the stimulatory effect of estrogens on proliferation of human endometrial adenocarcinoma cells显示文摘Graziani G Tentori L Portarena I 2003Endoccrinology2003,144,7:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费